|Bid||4.85 x 1000|
|Ask||5.49 x 800|
|Day's Range||4.83 - 5.94|
|52 Week Range||3.30 - 20.50|
|Beta (5Y Monthly)||1.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 23, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 24, 2005|
|1y Target Est||20.50|
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2022.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the company has received five new United States patents and seven new foreign patents in the last 12 months.